| Legal status | |
|---|---|
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C19H27N3O |
| Molar mass | 313.445 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MEPIRAPIM is anindole-basedcannabinoid which differs fromJWH-018 by having a 4-methylpiperazine group in place of the naphthyl group[1] and has been used as an active ingredient insynthetic cannabis products. It was first identified in Japan in 2013, alongsideFUBIMINA.[2] MEPIRAPIM acts as aT-type calcium channel inhibitor and is only minimally active at the CB1 receptor.[3]
Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.[4]
Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |